Correlation of molecular and clinically distinct phenotypes in HER2-overexpressing breast cancer (HER2+ BC) with estrogen receptor status (ER) status: Implications for anti-HER2 therapy.
Loi S, Haibe-Kains B, Brown D, Metallo J, Huan L, Desmedt C, Pusztai L, Piccart M, Esteva F, Sotiriou C. Correlation of molecular and clinically distinct phenotypes in HER2-overexpressing breast cancer (HER2+ BC) with estrogen receptor status (ER) status: Implications for anti-HER2 therapy. Journal Of Clinical Oncology 2010, 28: 522-522. DOI: 10.1200/jco.2010.28.15_suppl.522.Peer-Reviewed Original Research